New drug combo targets tough ovarian cancers
NCT ID NCT07593092
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests two experimental drugs, XmAb541 and XmAb808, in people with advanced ovarian cancer that has come back or spread. The main goal is to see if the combination is safe and find the best dose. About 90 adults with a specific tumor marker (CLDN6) will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Xencor Investigative Site
Detroit, Michigan, 48201, United States
-
Xencor Investigative Site
Omaha, Nebraska, 68198, United States
-
Xencor Investigative Site
Lake Success, New York, 11042, United States
-
Xencor Investigative Site
New York, New York, 10029, United States
-
Xencor Investigative Site
The Bronx, New York, 10461, United States
-
Xencor Investigative Site
Columbus, Ohio, 43210, United States
-
Xencor Investigative Site
Oklahoma City, Oklahoma, 73104, United States
-
Xencor Investigative Site
Fort Worth, Texas, 76104, United States
-
Xencor Investigative Site
Houston, Texas, 77030, United States